35
Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Clinical Challenges in the Patient With Multiply Relapsed Myeloma

  • Upload
    tamera

  • View
    56

  • Download
    0

Embed Size (px)

DESCRIPTION

Clinical Challenges in the Patient With Multiply Relapsed Myeloma. How would you approach this patient? As he was progressing on a bortezomib-based regimen, consider the pomalidomide/dexamethasone combination. Relapsed/Refractory MM New Proteasome Inhibitors . - PowerPoint PPT Presentation

Citation preview

Page 1: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Page 2: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 3: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 4: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 5: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 6: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 7: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

How would you approach this patient?

As he was progressing on a bortezomib-based regimen, consider the

pomalidomide/dexamethasone combination.

Page 8: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 9: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Relapsed/Refractory MMNew Proteasome Inhibitors

Page 10: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 11: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 12: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 13: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 14: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Relapsed/Refractory MMHDAC Inhibitors

Page 15: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 16: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 17: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 18: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Relapsed/Refractory MMAntibodies

Page 19: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 20: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 21: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 22: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 23: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 24: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 25: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Relapsed/Refractory MMChallenges Ahead

Page 26: Clinical Challenges in the Patient With Multiply Relapsed Myeloma
Page 27: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Abbreviations

Page 28: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

Abbreviations (cont)

Page 29: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References

Page 30: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)

Page 31: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)

Page 32: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)

Page 33: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)

Page 34: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)

Page 35: Clinical Challenges in the Patient With Multiply Relapsed Myeloma

References (cont)